Filing Details

Accession Number:
0001415889-24-021882
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-21 18:49:47
Reporting Period:
2024-08-20
Accepted Time:
2024-08-21 18:49:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671858 Ars Pharmaceuticals Inc. SPRY Pharmaceutical Preparations (2834) 811489190
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1794284 D. Kathleen Scott C/O Ars Pharmaceuticals, Inc.
11682 El Camino Real, Suite 120
San Diego CA 92130
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-20 12,500 $1.50 25,699 No 4 M Direct
Common Stock Disposition 2024-08-20 12,500 $16.00 13,199 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-08-20 12,500 $0.00 12,500 $1.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
814,830 2032-02-29 No 4 M Direct
Footnotes
  1. Includes 2,969 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") on June 30, 2023 and 1,980 shares acquired under the ESPP on June 28, 2024.
  2. The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.
  3. Immediately exercisable.